Pfizer and Moderna expanding vaccine studies in children 5 to 11, report says - CNET
Urged on by the Food and Drug Administration, COVID-19 vaccine creators Pfizer-BioNTech and Moderna are expanding their studies in children from 5 to 11 years of age, according to The New York Times on Monday.The study expansion reportedly aims to detect rare side effects like heart inflammation, which has shown up in vaccinated people under 30. .
Pediatric studies from Pfizer-BioNTech and Moderna were falling short in detecting such side effects, according to the report.